<DOC>
	<DOCNO>NCT00438061</DOCNO>
	<brief_summary>Abdominal obesity strongly associate dyslipidemia , may account associate increased risk atherosclerosis coronary disease . Weight reduction suggest preferred effective first-line strategy correct lipid abnormality , particularly overweight/obese subject . This improvement may relate effect reduction abdominal fat mass apoB apoA-I metabolism , remain fully demonstrate . Hypothesis : Reduction abdominal fat mass weight loss decrease apoB concentration raise HDL-cholesterol chiefly increase LDL-apoB fractional catabolic rate ( FCR ) , well decrease HDL apoA-I , respectively .</brief_summary>
	<brief_title>Effect Abdominal Obesity Lipoprotein Metabolism</brief_title>
	<detailed_description>We examine mechanism effect weight loss diet LDL HDL metabolism abdominally obese men . LDL apoB-100 HDL apoA-I kinetics study use primed-constant infusion 1- [ 13C ] -leucine control , dietary intervention trial 16 week duration middle-aged , obese men metabolic syndrome . Isotopic enrichment apoB apoA-I measure gas chromatography-mass spectrometry fractional turnover rate estimate use multi-compartmental modelling .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Obesity , Abdominal</mesh_term>
	<criteria>Obesity define body mass index ( BMI ) &gt; 28kg/m2 visceral visceral obesity ( waist hip ratio &gt; 1.0 waist circumference &gt; 100 cm ) Diabetes mellitus , Proteinuria , Hypothyroidism , Abnormal liver enzymes , Major systemic illness , A history alcohol abuse , A family history hyperlipidemia premature coronary artery disease take medication know affect lipid metabolism .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>Lipoprotein metabolism</keyword>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Obesity</keyword>
</DOC>